News and reflections from the world of AI

Aiforia appoints Swedbank as lead advisor to explore financing options

Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.

Interview with Dr. Rish Pai on using AI to study colorectal cancer

Introduction Colorectal cancer is the third most common cancer in the United States and pathologists are becoming increasingly valuable in the management of these patients. Analysis of histological features of the tumors is the main source of data for diagnosis, but there are many components to this. Routine pathologic assessment does not capture a quantitative view of the extensive variability ...

5 things to know about Aiforia 5.0

We are excited to share our latest software release, bringing Aiforia users increased convenience and confidence in their image analysis! Version 5.0 emphasizes our promise to guarantee security and privacy to researchers, scientists, and pathologists using our software. The latest release is also packed with new enhancements to key features, from image storage to analysis. 

Interview with CRL Pathologists on developing an AI model for DSS-induced colitis

Inflammatory Bowel Disease (IBD) is a debilitating disease for which no cures exists. Murine models are widely used to study IBD, amongst them, the DSS-colitis model is a rapid and reliable one. However the scoring of histopathological lesions is challenging. We interviewed veterinary pathologists at Charles River Laboratories, Dr. Agathe Bedard and Dr. Aleksandra Zuraw, on their recently ...

AI in toxicologic pathology publications’ summaries

AI-based bone marrow screening Screening For Bone Marrow Cellularity Changes in Cynomolgus Macaques in Toxicology Safety Studies Using Artificial Intelligence Models Mark A. Smith, Thomas Westerling-Bui, Angela Wilcox, Julie Schwartz

DECIDER project launches to improve diagnostics and treatment of ovarian cancer

The European Union has funded a project to improve personalized treatments for ovarian cancer with nearly 15 million euros for five years. The international DECIDER project has partners from 14 organizations in seven EU countries.